1. Non-invasive follicular neoplasm with papillary-like nuclear features: a challenging and infrequent entity in Argentina
- Author
-
Melina Saban, Norma Tolaba, Ana M Orlandi, Susana Deutsch, Fabián Pitoia, Alicia Lowenstein, Maria Cristina Calabrese, Andrea Cavallo, Alejandro Iotti, Marcelo Monteros Alvi, Marcelo Nallar, Ana Jaén, Silvina Figurelli, Fernando Carrizo, Antonio Colobraro, Gabriela García Tascón, María Saccoliti, Andrea Paez De Lima, Melisa Lencioni, Inés Califano, and Carmen Cabezón
- Subjects
Iodine Radioisotopes ,Thyroid Cancer, Papillary ,Adenocarcinoma, Follicular ,Argentina ,Humans ,Thyroid Neoplasms ,Retrospective Studies - Abstract
Purpose: Non-invasive encapsulated follicular variant of papillary thyroid cancer was reclassified as non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP). These neoplasms have an extremely low malignant potential. The aim of this study was 1) to assess the prevalence of NIFTP in patients with papillary thyroid carcinoma, 2) to evaluate their outcomes and 3) to determine their molecular profile.Methods: Multicenter, descriptive, retrospective study. Patients with papillary thyroid cancer diagnosed from January 2006 to December 2016 from 11 referral centers were included. Diagnosis of NIFTP was based on criteria described by Nikiforov et al. in 2018. At least two pathologists agreed on the diagnosis. Two thousand six hundred and seventy-seven papillary thyroid cancer patients were included; 456 (17%) of them were follicular variant papillary thyroid cancer, and 30 (1.12%) fulfilled diagnostic criteria for NIFTP.Results: Each of the 30 included patients underwent a total thyroidectomy, and 50% were treated with radioiodine (median dose 100 mCi). After a median follow up of 37 months, 84% of patients had an excellent response, 3% had an indeterminate response and data was missing in the remaining 13%. No metastatic lymph nodes, distant metastases or recurrences were found. RAS mutations were detected in 4 patients (13%).Conclusion: The prevalence of NIFTP in our series is amongst the lowest reported. Excellent outcomes of patients underscore their low malignant potential. Molecular findings differ from other series, probably related to environmental or ethnic features of our population and the meticulous criteria for diagnosing NIFTP.
- Published
- 2022
- Full Text
- View/download PDF